AstraZeneca partners with Quell Therapeutics to develop engineered Treg cell therapies
Under the agreement, AstraZeneca will harness Quell's distinctive arsenal of Treg cell engineering modules, which includes the groundbreaking…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
09 Jun 23
Under the agreement, AstraZeneca will harness Quell's distinctive arsenal of Treg cell engineering modules, which includes the groundbreaking…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
09 Jun 23
Certest, a company specialized in the development, manufacturing, and commercialization of solutions for the diagnosis of infectious diseases,…
09 Jun 23
Acquisition accelerates Cosette’s women’s health portfolio; with a differentiated, commercial stage, patent protected product
09 Jun 23
European champion committed to further extending global leadership in attractive and growing generics and biosimilars market, via purpose-driven…
08 Jun 23
The EC authorisation follows the positive recommendation by the European Medicines Agency’s (EMA) Committee for Medicinal Products for…
08 Jun 23
Under the partnership, more than 1,700 IHC-validated antibodies from CST detected by fluorescent secondary antibodies will be used…
08 Jun 23
Invistics’ Flowlytics solution utilises predictive analytics to identify illicit diversion of both controlled and non-controlled medications in patient…
08 Jun 23
The partnership will start with Enterprise Search in Generative AI App Builder to enhance the efficiency of clinical…
08 Jun 23
Cooperation between Abiec and Imaflora could increase the number of slaughterhouses that adopt unified socio-environmental criteria when buying…
08 Jun 23
Launches new “Food for Climate Solutions” grants program and recommits to its Environmental Education and Jane’s Fellowship programs